IDEXX Laboratories Inc (0J8P.L)

Name: IDEXX Laboratories Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Equipment Services

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$1.1B

Net Income

$248M

Operating Margin

28.9%

Free Cash Flow

$1.1B

Debt / Assets

52.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for IDEXX Laboratories Inc (0J8P.L).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	1,090,579,000	1,105,239,000	1,109,457,000	998,427,000
Cost of Revenue	432,465,000	421,885,000	414,725,000	375,048,000
Gross Profit	658,114,000	683,354,000	694,732,000	623,379,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	275,676,000	265,093,000	259,788,000	247,784,000
Operating Expenses	342,509,000	328,508,000	321,686,000	306,845,000
Operating Income	315,605,000	354,846,000	373,046,000	316,534,000
Interest Expense	8,623,000	10,655,000	11,321,000	7,666,000
Income Before Tax	306,982,000	344,771,000	362,352,000	310,084,000
Income Tax Expense	58,794,000	70,161,000	68,363,000	67,407,000
Net Income	248,188,000	274,610,000	293,989,000	242,677,000
Per Share
EPS	3.10	3.43	3.66	2.98
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for IDEXX Laboratories Inc (0J8P.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	4,303,702,000	3,897,504,000	3,660,953,000	3,367,324,000
Cost of Revenue	1,644,123,000	1,518,577,000	1,470,983,000	1,388,719,000
Gross Profit	2,659,579,000	2,378,927,000	2,189,970,000	1,978,605,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,048,341,000	1,030,798,000	901,891,000	849,553,000
Operating Expenses	1,299,548,000	1,250,590,000	1,092,842,000	1,102,173,000
Operating Income	1,360,031,000	1,128,337,000	1,097,128,000	876,432,000
Interest Expense	38,265,000	31,205,000	41,581,000	42,658,000
Income Before Tax	1,324,189,000	1,109,831,000	1,061,176,000	859,972,000
Income Tax Expense	264,725,000	221,964,000	216,134,000	180,883,000
Net Income	1,059,464,000	887,867,000	845,042,000	679,089,000
Per Share
EPS	13.17	10.77	10.17	8.12
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for IDEXX Laboratories Inc (0J8P.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	180,070,000	288,266,000	453,932,000	112,546,000
Short Term Investments	0	0	0	0
Net Receivables	552,378,000	561,316,000	529,528,000	490,903,000
Inventory	377,756,000	381,877,000	380,282,000	367,823,000
Total Current Assets	1,413,827,000	1,399,897,000	1,495,254,000	1,044,229,000
Property Plant Equipment	747,380,000	829,252,000	817,676,000	768,092,000
Goodwill and Intangibles	0	516,776,000	450,461,000	459,467,000
Total Assets	3,350,759,000	3,293,443,000	3,259,925,000	2,746,765,000
Liabilities
Account Payables	110,408,000	114,211,000	110,643,000	110,221,000
Short Term Debt	472,995,000	439,326,000	344,799,000	674,407,000
Total Current Liabilities	1,148,814,000	1,067,916,000	951,547,000	1,235,803,000
Long Term Debt	374,842,000	547,622,000	722,554,000	694,387,000
Total Liabilities	1,745,376,000	1,698,130,000	1,775,395,000	2,138,027,999
Shareholders Equity
Retained Earnings	0	5,332,438,000	4,444,571,000	3,599,529,000
Total Shareholders Equity	1,605,383,000	1,595,313,000	1,484,530,000	608,737,000

Balance sheet annual history for IDEXX Laboratories Inc (0J8P.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	180,070,000	288,266,000	453,932,000	112,546,000
Short Term Investments	0	0	0	0
Net Receivables	552,378,000	561,316,000	529,528,000	490,903,000
Inventory	377,756,000	381,877,000	380,282,000	367,823,000
Total Current Assets	1,413,827,000	1,399,897,000	1,495,254,000	1,044,229,000
Property Plant Equipment	747,380,000	829,252,000	817,676,000	768,092,000
Goodwill and Intangibles	0	516,776,000	450,461,000	459,467,000
Total Assets	3,350,759,000	3,293,443,000	3,259,925,000	2,746,765,000
Liabilities
Account Payables	110,408,000	114,211,000	110,643,000	110,221,000
Short Term Debt	472,995,000	439,326,000	344,799,000	674,407,000
Total Current Liabilities	1,148,814,000	1,067,916,000	951,547,000	1,235,803,000
Long Term Debt	374,842,000	547,622,000	722,554,000	694,387,000
Total Liabilities	1,745,376,000	1,698,130,000	1,775,395,000	2,138,027,999
Shareholders Equity
Retained Earnings	0	5,332,438,000	4,444,571,000	3,599,529,000
Total Shareholders Equity	1,605,383,000	1,595,313,000	1,484,530,000	608,737,000

Cash flow quarterly history for IDEXX Laboratories Inc (0J8P.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	1,059,464,000	887,867,000	845,042,000	679,089,000
Depreciation & Amortization	0	129,936,000	114,908,000	111,900,000
Stock Based Compensation	0	60,295,000	59,739,000	49,770,000
Change in Working Capital	-227,514,000	-133,238,000	-72,429,000	-273,530,000
Operating Cash Flow	1,181,805,000	929,001,000	906,510,000	542,549,000
Investing Activities
Capital Expenditure	-124,676,000	-130,922,000	-133,631,000	-158,838,000
Investments	-124,676,000	-120,922,000	-133,631,000	-158,838,000
Investing Cash Flow	-136,239,000	-207,062,000	-125,254,000	-195,350,000
Financing Activities
Debt Repayment	-30,385,000	-75,000,000	-404,000,000	-430,500,000
Common Stock Issued/Repurchased	-1,123,602,000	-792,542,000	-71,920,000	-783,964,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-1,164,964,000	-878,073,000	-441,996,000	-370,501,000
Summary
Free Cash Flow	1,057,129,000	798,079,000	772,879,000	383,711,000
Net Change in Cash	-108,196,000	-165,666,000	341,386,000	-31,908,000

Cash flow annual history for IDEXX Laboratories Inc (0J8P.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	1,059,464,000	887,867,000	845,042,000	679,089,000
Depreciation & Amortization	0	129,936,000	114,908,000	111,900,000
Stock Based Compensation	0	60,295,000	59,739,000	49,770,000
Change in Working Capital	-227,514,000	-133,238,000	-72,429,000	-273,530,000
Operating Cash Flow	1,181,805,000	929,001,000	906,510,000	542,549,000
Investing Activities
Capital Expenditure	-124,676,000	-130,922,000	-133,631,000	-158,838,000
Investments	-124,676,000	-120,922,000	-133,631,000	-158,838,000
Investing Cash Flow	-136,239,000	-207,062,000	-125,254,000	-195,350,000
Financing Activities
Debt Repayment	-30,385,000	-75,000,000	-404,000,000	-430,500,000
Common Stock Issued/Repurchased	-1,123,602,000	-792,542,000	-71,920,000	-783,964,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-1,164,964,000	-878,073,000	-441,996,000	-370,501,000
Summary
Free Cash Flow	1,057,129,000	798,079,000	772,879,000	383,711,000
Net Change in Cash	-108,196,000	-165,666,000	341,386,000	-31,908,000